-
1
-
-
0035806626
-
Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation / CRP evaluation (PRINCE): a randomized trial and cohort study
-
Albert, M.A., Danielson, E., Rifai, N. and Ridker, P.M. (2001) Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation / CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA 286: 64-70.
-
(2001)
JAMA
, vol.286
, pp. 64-70
-
-
Albert, M.A.1
Danielson, E.2
Rifai, N.3
Ridker, P.M.4
-
2
-
-
33947523389
-
Prior statin use may be associated with improved stroke outcome after tissue plasminogen activator
-
Alvarez-Sabin, J., Huertas, R., Quintana, M., Rubiera, M., Delgado, P., Ribo, M. et al. (2007) Prior statin use may be associated with improved stroke outcome after tissue plasminogen activator. Stroke 38: 1076-1078.
-
(2007)
Stroke
, vol.38
, pp. 1076-1078
-
-
Alvarez-Sabin, J.1
Huertas, R.2
Quintana, M.3
Rubiera, M.4
Delgado, P.5
Ribo, M.6
-
3
-
-
33746895436
-
High-dose atorvastatin after stroke or transient ischemic attack
-
Amarenco, P., Bogousslavsky, J., Callahan, A., 3rd, Goldstein, L.B., Hennerici, M., Rudolph, A.E. et al. (2006) High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 355: 549-559.
-
(2006)
N Engl J Med
, vol.355
, pp. 549-559
-
-
Amarenco, P.1
Bogousslavsky, J.2
Callahan, A.3.3
Goldstein, L.B.4
Hennerici, M.5
Rudolph, A.E.6
-
4
-
-
25144522575
-
Toward immunomodulatory and anti-inflammatory properties of statins
-
Arnaud, C., Braunersreuther, V. and Mach, F. (2005) Toward immunomodulatory and anti-inflammatory properties of statins. Trends Cardiovasc Med 15: 202-206.
-
(2005)
Trends Cardiovasc Med
, vol.15
, pp. 202-206
-
-
Arnaud, C.1
Braunersreuther, V.2
Mach, F.3
-
5
-
-
0036023515
-
Treatment with atorvastatin to the National Cholesterol Educational Program goal versus ‘usual’ care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study
-
Athyros, V.G., Papageorgiou, A.A., Mercouris, B.R., Athyrou, V.V., Symeonidis, A.N., Basayannis, E.O. et al. (2002). Treatment with atorvastatin to the National Cholesterol Educational Program goal versus ‘usual’ care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. Curr Med Res Opin 18: 220-228.
-
(2002)
Curr Med Res Opin
, vol.18
, pp. 220-228
-
-
Athyros, V.G.1
Papageorgiou, A.A.2
Mercouris, B.R.3
Athyrou, V.V.4
Symeonidis, A.N.5
Basayannis, E.O.6
-
6
-
-
33947517351
-
Cholesterol level and symptomatic hemorrhagic transformation after ischemic stroke thrombolysis
-
Bang, O.Y., Saver, J.L., Liebeskind, D.S., Starkman, S., Villablanca, P., Salamon, N. et al. (2007) Cholesterol level and symptomatic hemorrhagic transformation after ischemic stroke thrombolysis. Neurology 68: 737-742.
-
(2007)
Neurology
, vol.68
, pp. 737-742
-
-
Bang, O.Y.1
Saver, J.L.2
Liebeskind, D.S.3
Starkman, S.4
Villablanca, P.5
Salamon, N.6
-
7
-
-
0034115496
-
Pleiotropic effects of statins in atherosclerosis and diabetes
-
Bellosta, S., Ferri, N., Arnaboldi, L., Bernini, F., Paoletti, R. and Corsini, A. (2000) Pleiotropic effects of statins in atherosclerosis and diabetes. Diabetes Care 23 Suppl 2: B72-B78
-
(2000)
Diabetes Care 23 Suppl
, vol.2
, pp. B72-B78
-
-
Bellosta, S.1
Ferri, N.2
Arnaboldi, L.3
Bernini, F.4
Paoletti, R.5
Corsini, A.6
-
8
-
-
0031775709
-
HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages
-
Bellosta, S., Via, D., Canavesi, M., Pfister, P., Fumagalli, R., Paoletti, R. et al. (1998) HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages. Arterioscler Thromb Vasc Biol 18: 1671-1678.
-
(1998)
Arterioscler Thromb Vasc Biol
, vol.18
, pp. 1671-1678
-
-
Bellosta, S.1
Via, D.2
Canavesi, M.3
Pfister, P.4
Fumagalli, R.5
Paoletti, R.6
-
9
-
-
0028263188
-
Elevated serum cholesterol is a risk factor for both coronary heart disease and thromboembolic stroke in Hawaiian Japanese men. Implications of shared risk
-
Benfante, R., Yano, K., Hwang, L.J., Curb, J.D., Kagan, A. and Ross, W. (1994) Elevated serum cholesterol is a risk factor for both coronary heart disease and thromboembolic stroke in Hawaiian Japanese men. Implications of shared risk. Stroke 25: 814-820.
-
(1994)
Stroke
, vol.25
, pp. 814-820
-
-
Benfante, R.1
Yano, K.2
Hwang, L.J.3
Curb, J.D.4
Kagan, A.5
Ross, W.6
-
10
-
-
34548278923
-
Statin treatment withdrawal in ischemic stroke: a controlled randomized study
-
Blanco, M., Nombela, F., Castellanos, M., Rodriguez-Yanez, M., Garcia-Gil, M., Leira, R. et al. (2007) Statin treatment withdrawal in ischemic stroke: a controlled randomized study. Neurology 69: 904-910.
-
(2007)
Neurology
, vol.69
, pp. 904-910
-
-
Blanco, M.1
Nombela, F.2
Castellanos, M.3
Rodriguez-Yanez, M.4
Garcia-Gil, M.5
Leira, R.6
-
11
-
-
0031005723
-
Stroke, statins, and cholesterol. A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors
-
Blauw, G.J., Lagaay, A.M., Smelt, A.H. and Westendorp, R.G. (1997) Stroke, statins, and cholesterol. A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors. Stroke 28: 946-950.
-
(1997)
Stroke
, vol.28
, pp. 946-950
-
-
Blauw, G.J.1
Lagaay, A.M.2
Smelt, A.H.3
Westendorp, R.G.4
-
12
-
-
0030941803
-
The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor
-
Brown, M.S. and Goldstein, J.L. (1997) The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89: 331-340.
-
(1997)
Cell
, vol.89
, pp. 331-340
-
-
Brown, M.S.1
Goldstein, J.L.2
-
13
-
-
0038443056
-
Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke
-
Chen, J., Zhang, Z.G., Li, Y., Wang, Y., Wang, L., Jiang, H. et al. (2003) Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol 53: 743-751.
-
(2003)
Ann Neurol
, vol.53
, pp. 743-751
-
-
Chen, J.1
Zhang, Z.G.2
Li, Y.3
Wang, Y.4
Wang, L.5
Jiang, H.6
-
14
-
-
0037207278
-
Statin inhibits interferon-gamma-induced expression of intercellular adhesion molecule-1 (ICAM-1) in vascular endothelial and smooth muscle cells
-
Chung, H.K., Lee, I.K., Kang, H., Suh, J.M., Kim, H., Park, K.C. et al. (2002) Statin inhibits interferon-gamma-induced expression of intercellular adhesion molecule-1 (ICAM-1) in vascular endothelial and smooth muscle cells. Exp Mol Med 34: 451-461.
-
(2002)
Exp Mol Med
, vol.34
, pp. 451-461
-
-
Chung, H.K.1
Lee, I.K.2
Kang, H.3
Suh, J.M.4
Kim, H.5
Park, K.C.6
-
15
-
-
0027194791
-
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
-
Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W. et al. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923.
-
(1993)
Science
, vol.261
, pp. 921-923
-
-
Corder, E.H.1
Saunders, A.M.2
Strittmatter, W.J.3
Schmechel, D.E.4
Gaskell, P.C.5
Small, G.W.6
-
16
-
-
0035916233
-
Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization
-
Crisby, M., Nordin-Fredriksson, G., Shah, P.K., Yano, J., Zhu, J. and Nilsson, J. (2001) Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation 103: 926-933.
-
(2001)
Circulation
, vol.103
, pp. 926-933
-
-
Crisby, M.1
Nordin-Fredriksson, G.2
Shah, P.K.3
Yano, J.4
Zhu, J.5
Nilsson, J.6
-
17
-
-
2942720515
-
Beneficial cardiovascular pleiotropic effects of statins
-
Davignon, J. (2004) Beneficial cardiovascular pleiotropic effects of statins. Circulation 109: 11139-43.
-
(2004)
Circulation
, vol.109
, pp. 11139-11143
-
-
Davignon, J.1
-
18
-
-
0033965483
-
Akt takes center stage in angiogenesis signaling
-
Dimmeler, S. and Zeiher, A.M. (2000) Akt takes center stage in angiogenesis signaling. Circ Res 86: 4-5.
-
(2000)
Circ Res
, vol.86
, pp. 4-5
-
-
Dimmeler, S.1
Zeiher, A.M.2
-
19
-
-
0034908652
-
HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI3-kinase/Akt pathway
-
Dimmeler, S., Aicher, A., Vasa, M., Mildner-Rihm, C. Adler, K. and Tiėmann, M. (2001) HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI3-kinase/Akt pathway. J Clin Invest 108: 391-397.
-
(2001)
J Clin Invest
, vol.108
, pp. 391-397
-
-
Dimmeler, S.1
Aicher, A.2
Vasa, M.3
Mildner-Rihm, C.4
Adler, K.5
Tiėmann, M.6
-
20
-
-
0032488346
-
Blood pressure, cholesterol, and stroke in eastern Asia
-
Eastern Stroke and Coronary Heart Disease Collaborative Research Group
-
Eastern Stroke and Coronary Heart Disease Collaborative Research Group (1998) Blood pressure, cholesterol, and stroke in eastern Asia. Lancet 352: 1801-1807.
-
(1998)
Lancet
, vol.352
, pp. 1801-1807
-
-
-
21
-
-
0032555154
-
Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase
-
Endres, M., Laufs, U., Huang, Z., Nakamura, Y., Huang, P., Moskowitz, M.A. et al. (1998) Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci USA 95: 8880-8885.
-
(1998)
Proc Natl Acad Sci USA
, vol.95
, pp. 8880-8885
-
-
Endres, M.1
Laufs, U.2
Huang, Z.3
Nakamura, Y.4
Huang, P.5
Moskowitz, M.A.6
-
22
-
-
33748996772
-
Discontinuation of statin treatment in stroke patients
-
Endres, M. and Laufs, U. (2006) Discontinuation of statin treatment in stroke patients. Stroke 37: 2640-2643.
-
(2006)
Stroke
, vol.37
, pp. 2640-2643
-
-
Endres, M.1
Laufs, U.2
-
23
-
-
0037117639
-
Statin prevents tissue factor expression in human endothelial cells: role of Rho/Rho-kinase and Akt pathways
-
Eto, M., Kozai, T., Cosentino, F., Joch, H. and Luscher, T.F. (2002) Statin prevents tissue factor expression in human endothelial cells: role of Rho/Rho-kinase and Akt pathways. Circulation 105: 1756-1759.
-
(2002)
Circulation
, vol.105
, pp. 1756-1759
-
-
Eto, M.1
Kozai, T.2
Cosentino, F.3
Joch, H.4
Luscher, T.F.5
-
24
-
-
0033995229
-
Inhibition of tissue-factor-mediated thrombin generation by simvastatin
-
Ferro, D., Basili, S., Alessandri, C., Cara, D. and Violi, F. (2000) Inhibition of tissue-factor-mediated thrombin generation by simvastatin. Atherosclerosis 149: 111-116.
-
(2000)
Atherosclerosis
, vol.149
, pp. 111-116
-
-
Ferro, D.1
Basili, S.2
Alessandri, C.3
Cara, D.4
Violi, F.5
-
25
-
-
1442358521
-
Membrane cholesterol and the regulation of signal transduction
-
Fielding, C.J. and Fielding, P.E. (2004) Membrane cholesterol and the regulation of signal transduction. Biochemical Society transactions 32: 65-69.
-
(2004)
Biochemical Society transactions
, vol.32
, pp. 65-69
-
-
Fielding, C.J.1
Fielding, P.E.2
-
26
-
-
2342536907
-
Rosuvastatin reduces MMP-7 secretion by human monocyte-derived macrophages: potential relevance to atherosclerotic plaque stability
-
Furman, C., Copin, C., Kandoussi, M., Davidson, R., Moreau, M., McTaggiart, F. et al. (2004) Rosuvastatin reduces MMP-7 secretion by human monocyte-derived macrophages: potential relevance to atherosclerotic plaque stability. Atherosclerosis 174: 93-98.
-
(2004)
Atherosclerosis
, vol.174
, pp. 93-98
-
-
Furman, C.1
Copin, C.2
Kandoussi, M.3
Davidson, R.4
Moreau, M.5
McTaggiart, F.6
-
27
-
-
0038652166
-
Upregulation of CD40-CD40 ligand (CD154) in patients with acute cerebral ischemia
-
Garlichs, C.D., Kozina, S., Fateh-Moghadam, S., Handschu, R., Tomandl, B., Stumpf, C. et al. (2003) Upregulation of CD40-CD40 ligand (CD154) in patients with acute cerebral ischemia. Stroke 34: 1412-1418.
-
(2003)
Stroke
, vol.34
, pp. 1412-1418
-
-
Garlichs, C.D.1
Kozina, S.2
Fateh-Moghadam, S.3
Handschu, R.4
Tomandl, B.5
Stumpf, C.6
-
28
-
-
33745155419
-
Primary prevention of ischemic stroke: a guideline from the American Heart Association / American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline
-
Goldstein, L.B., Adams, R., Alberts, M.J., Appel, L.J., Brass, L.M., Bushnell, C.D. et al. (2006). Primary prevention of ischemic stroke: a guideline from the American Heart Association / American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke 37: 1583-1633.
-
(2006)
Stroke
, vol.37
, pp. 1583-1633
-
-
Goldstein, L.B.1
Adams, R.2
Alberts, M.J.3
Appel, L.J.4
Brass, L.M.5
Bushnell, C.D.6
-
29
-
-
0029100908
-
Molecular cloning and functional analysis of the promoter of the human squalene synthase gene
-
Guan, G., Jiang, G., Koch, R.L. and Shechter, I. (1995) Molecular cloning and functional analysis of the promoter of the human squalene synthase gene. J Biol Chem 270: 21958-21965.
-
(1995)
J Biol Chem
, vol.270
, pp. 21958-21965
-
-
Guan, G.1
Jiang, G.2
Koch, R.L.3
Shechter, I.4
-
30
-
-
0032494101
-
3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture
-
Guijarro, C., Blanco-Colio, L.M., Ortego, M., Alonso, C., Ortiz, A., Plaza, J.J. et al. (1998) 3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture. Circ Res 83: 490-500.
-
(1998)
Circ Res
, vol.83
, pp. 490-500
-
-
Guijarro, C.1
Blanco-Colio, L.M.2
Ortego, M.3
Alonso, C.4
Ortiz, A.5
Plaza, J.J.6
-
31
-
-
0030802435
-
Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials
-
Hebert, P.R., Gaziano, J.M., Chan, K.S. and Hennekens, C.H. (1997) Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials. JAMA 278: 313-321.
-
(1997)
JAMA
, vol.278
, pp. 313-321
-
-
Hebert, P.R.1
Gaziano, J.M.2
Chan, K.S.3
Hennekens, C.H.4
-
32
-
-
0346736491
-
Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells
-
Hernandez-Perera, O., Perez-Sala, D., Navarro-Antolin, J., Sanchez-Pascuala, R., Hernandez, G., Diaz, C. et al. (1998) Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. J Clin Invest 101: 2711-2719.
-
(1998)
J Clin Invest
, vol.101
, pp. 2711-2719
-
-
Hernandez-Perera, O.1
Perez-Sala, D.2
Navarro-Antolin, J.3
Sanchez-Pascuala, R.4
Hernandez, G.5
Diaz, C.6
-
33
-
-
33644550593
-
Statins prevent NF-κB transactivation independently of IKKpathway in human endothelial cells
-
Holschermann, H., Schuster, D., Parviz, B., Haberbosch, W., Tillmanns, H. and Muth, H. (2006) Statins prevent NF-κB transactivation independently of IKKpathway in human endothelial cells. Atherosclerosis 185: 240-245.
-
(2006)
Atherosclerosis
, vol.185
, pp. 240-245
-
-
Holschermann, H.1
Schuster, D.2
Parviz, B.3
Haberbosch, W.4
Tillmanns, H.5
Muth, H.6
-
34
-
-
0036864411
-
Sterol regulatory element-binding proteins: transcriptional activators of lipid synthesis
-
Horton, J.D. (2002) Sterol regulatory element-binding proteins: transcriptional activators of lipid synthesis. Biochemical Society transactions 30: 1091-1095.
-
(2002)
Biochemical Society transactions
, vol.30
, pp. 1091-1095
-
-
Horton, J.D.1
-
35
-
-
0036915094
-
Structural mechanism for statin inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase
-
Istvan, E.S. (2002) Structural mechanism for statin inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase. American heart journal 144: S27-S32
-
(2002)
American heart journal
, vol.144
, pp. S27-S32
-
-
Istvan, E.S.1
-
36
-
-
0035843962
-
Structural mechanism for statin inhibition of HMG-CoA reductase
-
Istvan, E.S. and Deisenhofer, J. (2001) Structural mechanism for statin inhibition of HMG-CoA reductase. Science 292: 1160-1164.
-
(2001)
Science
, vol.292
, pp. 1160-1164
-
-
Istvan, E.S.1
Deisenhofer, J.2
-
37
-
-
84993828148
-
-
Jacobson, J.R., Dudek, S.M., Birukov, K.G., Ye, S.Q., Grigoryev, D.N., Girgis, R.E. et al. (2004)
-
(2004)
-
-
Jacobson, J.R.1
Dudek, S.M.2
Birukov, K.G.3
Ye, S.Q.4
Grigoryev, D.N.5
Girgis, R.E.6
-
38
-
-
2342640996
-
Cytoskeletal activation and altered gene expression in endothelial barrier regulation by simvastatin
-
Cytoskeletal activation and altered gene expression in endothelial barrier regulation by simvastatin. Am J Respir Cell Mol Biol 30: 662-670.
-
Am J Respir Cell Mol Biol
, vol.30
, pp. 662-670
-
-
-
39
-
-
0038645309
-
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial)
-
Jones, P.H., Davidson, M.H., Stein, E.A., Bays, H.E., McKenney, J.M., Miller, E. et al. (2003) Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial). Am J Cardiol 92: 152-160.
-
(2003)
Am J Cardiol
, vol.92
, pp. 152-160
-
-
Jones, P.H.1
Davidson, M.H.2
Stein, E.A.3
Bays, H.E.4
McKenney, J.M.5
Miller, E.6
-
40
-
-
0032896636
-
Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions
-
Kaesemeyer, W.H., Caldwell, R.B., Huang, J. and Caldwell, R.W. (1999) Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions. J Am Coll Cardiol 33: 234-241.
-
(1999)
J Am Coll Cardiol
, vol.33
, pp. 234-241
-
-
Kaesemeyer, W.H.1
Caldwell, R.B.2
Huang, J.3
Caldwell, R.W.4
-
41
-
-
0033826581
-
The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals
-
Kureishi, Y., Luo, Z., Shiojima, I., Bialik, A., Fulton, D., Lefer, D.J. et al. (2000) The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med 6: 1004-1010.
-
(2000)
Nat Med
, vol.6
, pp. 1004-1010
-
-
Kureishi, Y.1
Luo, Z.2
Shiojima, I.3
Bialik, A.4
Fulton, D.5
Lefer, D.J.6
-
42
-
-
0034533147
-
Statins as a newly recognized type of immunomodulator
-
Kwak, B., Mulhaupt, F., Myit, S. and Mach, F. (2000) Statins as a newly recognized type of immunomodulator. Nat Med 6: 1399-1402.
-
(2000)
Nat Med
, vol.6
, pp. 1399-1402
-
-
Kwak, B.1
Mulhaupt, F.2
Myit, S.3
Mach, F.4
-
43
-
-
0035102526
-
The HMG-CoA reductase inhibitor simvastatin inhibits IFN-gamma induced MHC class II expression in human vascular endothelial cells
-
Kwak, B., Mulhaupt, F., Veillard, N., Pelli, G. and Mach, F. (2001) The HMG-CoA reductase inhibitor simvastatin inhibits IFN-gamma induced MHC class II expression in human vascular endothelial cells. Swiss Med Wkly 131: 41-46.
-
(2001)
Swiss Med Wkly
, vol.131
, pp. 41-46
-
-
Kwak, B.1
Mulhaupt, F.2
Veillard, N.3
Pelli, G.4
Mach, F.5
-
44
-
-
0037154549
-
PPARgamma but not PPARalpha ligands are potent repressors of major histocompatibility complex class II induction in atheroma-associated cells
-
Kwak, B.R., Myit, S., Mulhaupt, F., Veillard, N., Rufer, N., Roosnek, E. et al. (2002) PPARgamma but not PPARalpha ligands are potent repressors of major histocompatibility complex class II induction in atheroma-associated cells. Circ Res 90: 356-362.
-
(2002)
Circ Res
, vol.90
, pp. 356-362
-
-
Kwak, B.R.1
Myit, S.2
Mulhaupt, F.3
Veillard, N.4
Rufer, N.5
Roosnek, E.6
-
45
-
-
0037353970
-
Beyond lipid-lowering: effects of statins on endothelial nitric oxide
-
Laufs, U. (2003) Beyond lipid-lowering: effects of statins on endothelial nitric oxide. Eur J Clin Pharmacol 58: 719-731.
-
(2003)
Eur J Clin Pharmacol
, vol.58
, pp. 719-731
-
-
Laufs, U.1
-
46
-
-
0037189048
-
Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice
-
Laufs, U., Gertz, K., Dirnagl, U., Bohm, M., Nickenig, G. and Endres, M. (2002) Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice. Brain Res 942: 23-30.
-
(2002)
Brain Res
, vol.942
, pp. 23-30
-
-
Laufs, U.1
Gertz, K.2
Dirnagl, U.3
Bohm, M.4
Nickenig, G.5
Endres, M.6
-
47
-
-
0032508533
-
Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase
-
Laufs, U. and Liao, J.K. (1998) Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem 273: 24266-24271.
-
(1998)
J Biol Chem
, vol.273
, pp. 24266-24271
-
-
Laufs, U.1
Liao, J.K.2
-
48
-
-
0033618378
-
3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing rho GTPase-induced down-regulation of p27(Kip1)
-
Laufs, U., Marra, D., Node, K. and Liao, J.K. (1999) 3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing rho GTPase-induced down-regulation of p27(Kip1). J Biol Chem 274: 21926-21931.
-
(1999)
J Biol Chem
, vol.274
, pp. 21926-21931
-
-
Laufs, U.1
Marra, D.2
Node, K.3
Liao, J.K.4
-
49
-
-
0034687606
-
Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of Rho GTPase gene transcription
-
Laufs, U., Endres, M., Custodis, F., Gertz, K., Nickenig, G. and Liao, J.K. (2000) Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of Rho GTPase gene transcription. Circulation 102: 3104-3110.
-
(2000)
Circulation
, vol.102
, pp. 3104-3110
-
-
Laufs, U.1
Endres, M.2
Custodis, F.3
Gertz, K.4
Nickenig, G.5
Liao, J.K.6
-
50
-
-
0036905152
-
Low concentration of serum total cholesterol is associated with multifocal signal loss lesions on gradient-echo magnetic resonance imaging: analysis of risk factors for multifocal signal loss lesions
-
Lee, S.H., Bae, H.J., Yoon, B.W., Kim, H., Kim, D.E. and Roh, J.K. (2002) Low concentration of serum total cholesterol is associated with multifocal signal loss lesions on gradient-echo magnetic resonance imaging: analysis of risk factors for multifocal signal loss lesions. Stroke 33: 2845-2849.
-
(2002)
Stroke
, vol.33
, pp. 2845-2849
-
-
Lee, S.H.1
Bae, H.J.2
Yoon, B.W.3
Kim, H.4
Kim, D.E.5
Roh, J.K.6
-
51
-
-
0034898468
-
HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells
-
Llevadot, J., Murasawa, S., Kureishi, Y., Uchida, S., Masuda, H. and Kawamoto, A. (2001) HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J Clin Invest 108: 399-405.
-
(2001)
J Clin Invest
, vol.108
, pp. 399-405
-
-
Llevadot, J.1
Murasawa, S.2
Kureishi, Y.3
Uchida, S.4
Masuda, H.5
Kawamoto, A.6
-
52
-
-
11144357096
-
Favorable outcome of ischemic stroke in patients pretreated with statins
-
Marti-Fabregas, J., Gomis, M., Arboix, A., Aleu, A., Pagonabarraga, J., Belvis, R. et al. (2004) Favorable outcome of ischemic stroke in patients pretreated with statins. Stroke 35: 1117-1121.
-
(2004)
Stroke
, vol.35
, pp. 1117-1121
-
-
Marti-Fabregas, J.1
Gomis, M.2
Arboix, A.3
Aleu, A.4
Pagonabarraga, J.5
Belvis, R.6
-
53
-
-
0344625376
-
Mevalonate deprivation impairs IGF-I/insulin signaling in human vascular smooth muscle cells
-
Martinez-Gonzalez, J., Vinals, M., Vidal, F., Llorente-Cortes, V. and Badimon, L. (1997) Mevalonate deprivation impairs IGF-I/insulin signaling in human vascular smooth muscle cells. Atherosclerosis 135: 213-223.
-
(1997)
Atherosclerosis
, vol.135
, pp. 213-223
-
-
Martinez-Gonzalez, J.1
Vinals, M.2
Vidal, F.3
Llorente-Cortes, V.4
Badimon, L.5
-
55
-
-
0024971244
-
Loss of transcriptional repression of three sterol-regulated genes in mutant hamster cells
-
Metherall, J.E., Goldstein, J.L., Luskey, K.L. and Brown, M.S. (1989) Loss of transcriptional repression of three sterol-regulated genes in mutant hamster cells. J Biol Chem 264: 15634-15641.
-
(1989)
J Biol Chem
, vol.264
, pp. 15634-15641
-
-
Metherall, J.E.1
Goldstein, J.L.2
Luskey, K.L.3
Brown, M.S.4
-
56
-
-
17344385356
-
The effect of statins on mRNA levels of genes related to inflammation, coagulation, and vascular constriction in HUVEC. Human umbilical vein endothelial cells
-
Morikawa, S., Takabe, W., Mataki, C., Kanke, T., Itoh, T., Wada, Y. et al. (2002) The effect of statins on mRNA levels of genes related to inflammation, coagulation, and vascular constriction in HUVEC. Human umbilical vein endothelial cells. J Atheroscler Thromb 9: 178-183.
-
(2002)
J Atheroscler Thromb
, vol.9
, pp. 178-183
-
-
Morikawa, S.1
Takabe, W.2
Mataki, C.3
Kanke, T.4
Itoh, T.5
Wada, Y.6
-
57
-
-
0036307360
-
SREBP-2 and NF-Y are involved in the transcriptional regulation of squalene epoxidase
-
Nagai, M., Sakakibara, J., Nakamura Y., Gejyo, F. and Ono, T. (2002) SREBP-2 and NF-Y are involved in the transcriptional regulation of squalene epoxidase. Biochemical and Biophysical Research Communications 295: 74-80.
-
(2002)
Biochemical and Biophysical Research Communications
, vol.295
, pp. 74-80
-
-
Nagai, M.1
Sakakibara, J.2
Nakamura, Y.3
Gejyo, F.4
Ono, T.5
-
58
-
-
0029877460
-
Transcriptional regulation of squalene epoxidase by sterols and inhibitors in HeLa cells
-
Nakamura, Y., Sakakibara, J., Izumi, T., Shibata, A. and Ono, T. (1996) Transcriptional regulation of squalene epoxidase by sterols and inhibitors in HeLa cells. J Biol Chem 271: 8053-8056.
-
(1996)
J Biol Chem
, vol.271
, pp. 8053-8056
-
-
Nakamura, Y.1
Sakakibara, J.2
Izumi, T.3
Shibata, A.4
Ono, T.5
-
59
-
-
0035897696
-
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)
-
Ncep (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285: 2486-2497.
-
(2001)
JAMA
, vol.285
, pp. 2486-2497
-
-
Ncep1
-
60
-
-
0142197165
-
Atorvastatin and omega-3 fatty acids protect against activation of the coagulation system in patients with combined hyperlipemia
-
Nordoy, A., Svensson, B. and Hansen, J.B. (2003) Atorvastatin and omega-3 fatty acids protect against activation of the coagulation system in patients with combined hyperlipemia. J Thromb Haemost 1: 690-697.
-
(2003)
J Thromb Haemost
, vol.1
, pp. 690-697
-
-
Nordoy, A.1
Svensson, B.2
Hansen, J.B.3
-
61
-
-
0025739267
-
Single nucleotide resolution of sterol regulatory region in promoter for 3-hydroxy-3-methylglutaryl coenzyme A reductase
-
Osborne, T.F. (1991) Single nucleotide resolution of sterol regulatory region in promoter for 3-hydroxy-3-methylglutaryl coenzyme A reductase. J Biol Chem 266: 13947-13951.
-
(1991)
J Biol Chem
, vol.266
, pp. 13947-13951
-
-
Osborne, T.F.1
-
62
-
-
0035076108
-
Regulation of endothelial nitric oxide synthase and endothelin-1 expression by fluvastatin in human vascular endothelial cells
-
Ozaki, K., Yamamoto, T., Ishibashi, T., Matsubara, T., Nishio, M. and Aizawa, Y. ( 2001) Regulation of endothelial nitric oxide synthase and endothelin-1 expression by fluvastatin in human vascular endothelial cells. Jpn J Pharmacol 85: 147-154.
-
(2001)
Jpn J Pharmacol
, vol.85
, pp. 147-154
-
-
Ozaki, K.1
Yamamoto, T.2
Ishibashi, T.3
Matsubara, T.4
Nishio, M.5
Aizawa, Y.6
-
63
-
-
22844434684
-
Statins exert endothelial atheroprotective effects via the KLF 2 transcription factor
-
Parmar, K.M., Nambudiri, V., Dai, G., Larman, H.B., Gimbrone, M.A., Jr. and Garcia-Cardena, G. (2005) Statins exert endothelial atheroprotective effects via the KLF 2 transcription factor. J Biol Chem 280: 26714-26719.
-
(2005)
J Biol Chem
, vol.280
, pp. 26714-26719
-
-
Parmar, K.M.1
Nambudiri, V.2
Dai, G.3
Larman, H.B.4
Gimbrone, M.J.5
Garcia-Cardena, G.6
-
64
-
-
84993744958
-
Simvastatin reduces the association of NMDA receptors to lipid rafts: a cholesterol mediated effect in neuroprotection
-
(in press)
-
Ponce, J., Pérez de la Ossa, N., Hurtado, O., Millan, M., Arenillas, J., Dávalos, A. et al. (2007) Simvastatin reduces the association of NMDA receptors to lipid rafts: a cholesterol mediated effect in neuroprotection. Stroke (in press).
-
(2007)
Stroke
-
-
Ponce, J.1
Pérez de la Ossa, N.2
Hurtado, O.3
Millan, M.4
Arenillas, J.5
Dávalos, A.6
-
65
-
-
0343273397
-
Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration
-
Prospective studies collaboration
-
Prospective studies collaboration (1995) Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration. Lancet 346: 1647-1653.
-
(1995)
Lancet
, vol.346
, pp. 1647-1653
-
-
-
66
-
-
0035587158
-
Diverse effects of inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase on the expression of VCAM-1 and E-selectin in endothelial cells
-
Rasmussen, L.M., Hansen, P.R., Nabipour, M.T., Olesen, P., Kristiansen, M.T. and Ledet, T. (2001) Diverse effects of inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase on the expression of VCAM-1 and E-selectin in endothelial cells. Biochem J 360: 363-370.
-
(2001)
Biochem J
, vol.360
, pp. 363-370
-
-
Rasmussen, L.M.1
Hansen, P.R.2
Nabipour, M.T.3
Olesen, P.4
Kristiansen, M.T.5
Ledet, T.6
-
67
-
-
12244292690
-
Preclinical pharmacokinetics of statins
-
Reinoso, R.F., Sanchez Navarro, A., Garcia, M.J. and Prous, J.R. (2002) Preclinical pharmacokinetics of statins. Methods and Findings in Experimental and Clinical Pharmacology 24: 593-613.
-
(2002)
Methods and Findings in Experimental and Clinical Pharmacology
, vol.24
, pp. 593-613
-
-
Reinoso, R.F.1
Sanchez Navarro, A.2
Garcia, M.J.3
Prous, J.R.4
-
68
-
-
0033587667
-
Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators
-
Ridker, P.M., Rifai, N., Pfeffer, M.A., Sacks, F. and Braunwald, E. (1999) Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. Circulation 100: 230-235.
-
(1999)
Circulation
, vol.100
, pp. 230-235
-
-
Ridker, P.M.1
Rifai, N.2
Pfeffer, M.A.3
Sacks, F.4
Braunwald, E.5
-
69
-
-
33645737200
-
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A statement for Healthcare Professionals from the American Heart Association / American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline
-
Sacco, R.L., Adams, R., Albers, G., Alberts, M.J., Benavente, O., Furie, K., et al. (2006). Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A statement for Healthcare Professionals from the American Heart Association / American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline. Circulation 113: e409-e449.
-
(2006)
Circulation
, vol.113
, pp. e409-e449
-
-
Sacco, R.L.1
Adams, R.2
Albers, G.3
Alberts, M.J.4
Benavente, O.5
Furie, K.6
-
70
-
-
0035872757
-
Inhibition of interferon-gamma-mediated microvascular endothelial cell major histocompatibility complex class II gene activation by HMG-CoA reductase inhibitors
-
Sadeghi, M.M., Tiglio, A., Sadigh, K., O'Donnell, L., Collinge, M., Pardi, R. et al. (2001) Inhibition of interferon-gamma-mediated microvascular endothelial cell major histocompatibility complex class II gene activation by HMG-CoA reductase inhibitors. Transplantation 71: 1262-1268.
-
(2001)
Transplantation
, vol.71
, pp. 1262-1268
-
-
Sadeghi, M.M.1
Tiglio, A.2
Sadigh, K.3
O'Donnell, L.4
Collinge, M.5
Pardi, R.6
-
71
-
-
33646065014
-
Effect of statins on platelet PAR-1 thrombin receptor in patients with the metabolic syndrome (from the PAR-1 inhibition by statins [PARIS] study)
-
Serebruany, V.L., Miller, M., Pokov, A.N., Malinin, A.I., Lowry, D.R., Tanguay, J.F. et al. (2006) Effect of statins on platelet PAR-1 thrombin receptor in patients with the metabolic syndrome (from the PAR-1 inhibition by statins [PARIS] study). Am J Cardiol 97: 1332-1336.
-
(2006)
Am J Cardiol
, vol.97
, pp. 1332-1336
-
-
Serebruany, V.L.1
Miller, M.2
Pokov, A.N.3
Malinin, A.I.4
Lowry, D.R.5
Tanguay, J.F.6
-
72
-
-
84993758504
-
-
Sever, P.S., Dahlöf, B., Poulter, N.R., Wedel, H., Beevers, G., Caulfield, M. et al. (2003). Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations,
-
(2003)
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations
-
-
Sever, P.S.1
Dahlöf, B.2
Poulter, N.R.3
Wedel, H.4
Beevers, G.5
Caulfield, M.6
-
73
-
-
68749114831
-
in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
-
in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 361: 1149-1158.
-
Lancet
, vol.361
, pp. 1149-1158
-
-
-
74
-
-
14644432487
-
Rosuvastatin, but not simvastatin, provides end-organ protection in stroke-prone rats by antiinflammatory effects
-
Sironi, L., Gianazza, E., Gelosa, P., Guerrini, U., Nobili, E., Gianella, A. et al. (2005) Rosuvastatin, but not simvastatin, provides end-organ protection in stroke-prone rats by antiinflammatory effects. Arterioscler Thromb Vasc Biol 25: 598-603.
-
(2005)
Arterioscler Thromb Vasc Biol
, vol.25
, pp. 598-603
-
-
Sironi, L.1
Gianazza, E.2
Gelosa, P.3
Guerrini, U.4
Nobili, E.5
Gianella, A.6
-
76
-
-
0025111798
-
Identification of nucleotides responsible for enhancer activity of sterol regulatory element in low density lipoprotein receptor gene
-
Smith, J.R., Osborne, T.F., Goldstein, J.L. and Brown, M.S. (1990) Identification of nucleotides responsible for enhancer activity of sterol regulatory element in low density lipoprotein receptor gene. J Biol Chem 265: 2306-2310.
-
(1990)
J Biol Chem
, vol.265
, pp. 2306-2310
-
-
Smith, J.R.1
Osborne, T.F.2
Goldstein, J.L.3
Brown, M.S.4
-
77
-
-
0028177562
-
Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol
-
Sparks, D.L., Scheff, S.W., Hunsaker, J.C., 3rd, Liu, H., Landers, T. and Gross, D.R. (1994) Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp Neurol 126: 88-94.
-
(1994)
Exp Neurol
, vol.126
, pp. 88-94
-
-
Sparks, D.L.1
Scheff, S.W.2
Hunsaker, J.3.3
Liu, H.4
Landers, T.5
Gross, D.R.6
-
78
-
-
0026629306
-
Molecular cloning and promoter analysis of the rat liver farnesyl diphosphate synthase gene
-
Spear, D.H., Kutsunai, S.Y., Correll, C.C. and Edwards, P.A. (1992) Molecular cloning and promoter analysis of the rat liver farnesyl diphosphate synthase gene. J Biol Chem 267: 14462-14469.
-
(1992)
J Biol Chem
, vol.267
, pp. 14462-14469
-
-
Spear, D.H.1
Kutsunai, S.Y.2
Correll, C.C.3
Edwards, P.A.4
-
79
-
-
0036480387
-
State of the art in cholesterol management: targeting multiple pathways
-
discussion S45-27
-
Turley, S.D. (2002) State of the art in cholesterol management: targeting multiple pathways. Am J Manag Care 8: S29-S32; discussion S45-27.
-
(2002)
Am J Manag Care
, vol.8
, pp. S29-S32
-
-
Turley, S.D.1
-
80
-
-
0035826856
-
Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V., and factor XIII and by enhancing factor Va inactivation
-
Undas, A., Brummel, K.E., Musial, J., Mann, K.G. and Szczeklik, A. (2001) Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation. Circulation 103: 2248-2253.
-
(2001)
Circulation
, vol.103
, pp. 2248-2253
-
-
Undas, A.1
Brummel, K.E.2
Musial, J.3
Mann, K.G.4
Szczeklik, A.5
-
81
-
-
0037023634
-
Double-edged role of statins in angiogenesis signaling
-
Urbich, C., Dernbach, E., Zeiher, A.M. and Dimmeler, S. (2002) Double-edged role of statins in angiogenesis signaling. Circ Res 90: 737-744.
-
(2002)
Circ Res
, vol.90
, pp. 737-744
-
-
Urbich, C.1
Dernbach, E.2
Zeiher, A.M.3
Dimmeler, S.4
-
82
-
-
0035912855
-
Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease
-
Vasa, M., Fichtlscherer, S., Adler, K., Aicher, A., Martin, H., Zeiher, A.M. and Dimmeler, S. (2001) Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 103: 2885-2890.
-
(2001)
Circulation
, vol.103
, pp. 2885-2890
-
-
Vasa, M.1
Fichtlscherer, S.2
Adler, K.3
Aicher, A.4
Martin, H.5
Zeiher, A.M.6
Dimmeler, S.7
-
83
-
-
0036120428
-
Cerivastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductase, inhibits endothelial cell proliferation induced by angiogenic factors in vitro and angiogenesis in in vivo models
-
Vincent, L., Soria, C., Mirshahi, F., Opolon, P., Mishal, Z., Vannier, J.P. et al. (2002) Cerivastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductase, inhibits endothelial cell proliferation induced by angiogenic factors in vitro and angiogenesis in in vivo models. Arterioscler Thromb Vasc Biol 22: 623-629.
-
(2002)
Arterioscler Thromb Vasc Biol
, vol.22
, pp. 623-629
-
-
Vincent, L.1
Soria, C.2
Mirshahi, F.3
Opolon, P.4
Mishal, Z.5
Vannier, J.P.6
-
84
-
-
0037167661
-
Effects of atorvastatin on stroke in patients with unstable angina or non-Q-wave myocardial infarction: a Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) substudy
-
Waters, D.D., Schwartz, G.G., Olsson, A.G., Zeiher, A., Oliver, M.F., Ganz, P. et al. (2002) Effects of atorvastatin on stroke in patients with unstable angina or non-Q-wave myocardial infarction: a Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) substudy. Circulation 106: 1690-1695.
-
(2002)
Circulation
, vol.106
, pp. 1690-1695
-
-
Waters, D.D.1
Schwartz, G.G.2
Olsson, A.G.3
Zeiher, A.4
Oliver, M.F.5
Ganz, P.6
-
85
-
-
0034948339
-
Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site
-
Weitz-Schmidt, G., Welzenbach, K., Brinkmann, V., Kamata, T., Kallen, J., Bruns, C. et al. (2001) Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat Med 7: 687-692.
-
(2001)
Nat Med
, vol.7
, pp. 687-692
-
-
Weitz-Schmidt, G.1
Welzenbach, K.2
Brinkmann, V.3
Kamata, T.4
Kallen, J.5
Bruns, C.6
-
86
-
-
26844468578
-
Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy
-
Wiviott, S.D., Cannon, C.P., Morrow, D.A., Ray, K.K., Pfeffer, M.A. and Braunwald, E. (2005) Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy. J Am Coll Cardiol 46: 1411-1416.
-
(2005)
J Am Coll Cardiol
, vol.46
, pp. 1411-1416
-
-
Wiviott, S.D.1
Cannon, C.P.2
Morrow, D.A.3
Ray, K.K.4
Pfeffer, M.A.5
Braunwald, E.6
-
87
-
-
0024418221
-
Serum cholesterol and hemorrhagic stroke in the Honolulu Heart Program
-
Yano, K., Reed, D.M. and MacLean, C.J. (1989) Serum cholesterol and hemorrhagic stroke in the Honolulu Heart Program. Stroke 20: 1460-1465.
-
(1989)
Stroke
, vol.20
, pp. 1460-1465
-
-
Yano, K.1
Reed, D.M.2
MacLean, C.J.3
-
88
-
-
0346749450
-
3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect cortical neurons from excitotoxicity
-
Zacco, A., Togo, J., Spence, K., Ellis, A., Lloyd, D., Furlong, S. and Piser, T. (2003) 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect cortical neurons from excitotoxicity. J Neurosci 23: 11104-11111.
-
(2003)
J Neurosci
, vol.23
, pp. 11104-11111
-
-
Zacco, A.1
Togo, J.2
Spence, K.3
Ellis, A.4
Lloyd, D.5
Furlong, S.6
Piser, T.7
-
89
-
-
33644874287
-
Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat
-
Zhang, L., Zhang, Z.G., Ding, G.L., Jiang, Q., Liu, X., Meng, H. et al. (2005) Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat. Circulation 112: 3486-3494.
-
(2005)
Circulation
, vol.112
, pp. 3486-3494
-
-
Zhang, L.1
Zhang, Z.G.2
Ding, G.L.3
Jiang, Q.4
Liu, X.5
Meng, H.6
|